Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications increasingly prescribed in the UK for type 2 diabetes management and, in specific cases, for weight management in adults with obesity
Liraglutide reduces oxidative stress and improves energy metabolism in methylglyoxal-induced SH-SY5Y cells
Tirzepatide: the dual-action option Tirzepatide is a dual GLP-1/GIP receptor agonist
Combined activation of GLP-1, GIP, and GCG systems theoretically provides complementary mechanisms: GLP-1-mediated insulin sensitization and satiety promotion, GIP-mediated enhancement of insulin secretion and adipose lipid buffering, and glucagon-mediated direct hepatic lipid oxidation and energy expenditure augmentation
After receiving LG, only a tiny portion of patients with NASH showed progression (129)
So let us get more specific